Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health care competition law

This article was originally published in The Gray Sheet

Executive Summary

Federal Trade Commission workshop will focus on health care financing and delivery Sept. 9-10 in Washington, D.C. Panels will feature discussions on insurance payer/provider issues and GPOs; written comments are due Sept. 30. The meeting is unrelated to FTC's Internet anticompetition workshop, scheduled for Oct. 8-10 (11"The Gray Sheet" July 22, 2002, p. 11)...

You may also be interested in...



Internet Anti-Competition Project Brings Devices, Contacts Under FTC’s Eye

The Federal Trade Commission will highlight contact lens and other medical supply industries during an upcoming public workshop exploring possible anti-competitive efforts that restrict e-commerce

Could Revisiting US Approval Decisions Become Less Rare?

While not identifying specific situations raising potential questions, the FDA commissioner uses his appearance at agency's annual rare disease event to advise regulatory decisions may be revisited as more data becomes available. 

NGM’s Pan-FGF Receptor Approach In NASH Shows Benefits And Drawbacks

NGM’s Phase II data for FGF19 analog aldafermin shows ability to reduce liver fat and improve fibrosis, but also raises LDL-C. Company says it gets a broader effect this way and can manage the increased cholesterol.

UsernamePublicRestriction

Register

MT016996

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel